Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06689891 · ClinicalTrials.gov registry record · NA
Video-Based Pelvic Floor Muscle Therapy
A NA study of Pelvic Floor Disorder and Pelvic Floor Muscle Exercise, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06689891: Recruiting NA study of Pelvic Floor Disorder and Pelvic Floor Muscle Exercise, sponsored by Yale University.
NCT06689891 is a NA study of Pelvic Floor Disorder and Pelvic Floor Muscle Exercise that is actively recruiting participants, run by Yale University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06689891, a NA study of Pelvic Floor Disorder and Pelvic Floor Muscle Exercise, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a feasibility, pilot trial of remote, video-based pelvic floor muscle therapy (PFMT) for patients with pelvic floor disorders, including pelvic organ prolapse, urinary incontinence and anorectal dysfunction. PFMT has been shown to improve these symptoms in multiple studies.
Primary Outcome
The SUS is a 10-question survey that measures how easy a product or system is to use. Total score range from 0-100 with higher scores indicating better usability.
Conditions Studied
Interventions
- DEVICE Pelvic Floor Muscle Therapy Website
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-09 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06689891 shows while recruiting
NCT06689891 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Pelvic Floor Disorder appearing as the primary indexed condition, and to 1 intervention - of which Pelvic Floor Muscle Therapy Website is the first listed.
NCT06689891 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06689891 about?
NCT06689891 is a clinical study titled "Video-Based Pelvic Floor Muscle Therapy". This study is a feasibility, pilot trial of remote, video-based pelvic floor muscle therapy (PFMT) for patients with pelvic floor disorders, including pelvic organ prolapse, urinary incontinence and anorectal dysfunction. PFMT has been shown to improve these symptoms in multiple studies.
What is the current status of trial NCT06689891?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-09. Estimated completion is 2026-12.
What conditions does trial NCT06689891 study?
This clinical trial studies the following conditions: Pelvic Floor Disorder, Pelvic Floor Muscle Exercise.
What interventions are being tested in trial NCT06689891?
The interventions under investigation include: Pelvic Floor Muscle Therapy Website (DEVICE).
Who is sponsoring clinical trial NCT06689891?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06689891 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Floor Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06689891's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI